Log In
Print this Print this


Also known as: rhHIP/PAP

  Manage Alerts
Collapse Summary General Information
Company Alfact Innovation S.A.S.
DescriptionRecombinant human hepatocarcinoma-intestine-pancreas/pancreatic-associated protein (HIP/PAP)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationLiver failure
Indication DetailsTreat acute liver failure; Treat HBV- and autoimmune-related acute-on-chronic liver disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today